vs
Beam Therapeutics Inc.（BEAM）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
Ribbon Communications Inc.的季度营收约是Beam Therapeutics Inc.的1.4倍（$162.6M vs $114.1M），Beam Therapeutics Inc.净利率更高（214.1% vs 54.8%，领先159.3%），Beam Therapeutics Inc.同比增速更快（279.5% vs -10.3%）
Beam Therapeutics是一家美国生物技术企业，专注于基因治疗与基因组编辑领域的研发，总部位于马萨诸塞州剑桥市。公司依托CRISPR碱基编辑和先导编辑技术，可通过酶促作用修改DNA序列中的单个核苷酸，且不会造成DNA双链断裂，以此开发相关治疗方案。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
BEAM vs RBBN — 直观对比
营收规模更大
RBBN
是对方的1.4倍
$114.1M
营收增速更快
BEAM
高出289.8%
-10.3%
净利率更高
BEAM
高出159.3%
54.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $162.6M |
| 净利润 | $244.3M | $89.1M |
| 毛利率 | — | 42.9% |
| 营业利润率 | -15.3% | 37.6% |
| 净利率 | 214.1% | 54.8% |
| 营收同比 | 279.5% | -10.3% |
| 净利润同比 | 370.4% | — |
| 每股收益（稀释后） | $2.53 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEAMRBBN
| Q1 26 | — | $162.6M | ||
| Q4 25 | $114.1M | $227.3M | ||
| Q3 25 | — | $215.4M | ||
| Q2 25 | — | $220.6M | ||
| Q1 25 | — | $181.3M | ||
| Q4 24 | — | $251.4M | ||
| Q3 24 | — | $210.2M | ||
| Q2 24 | — | $192.6M |
净利润BEAMRBBN
| Q1 26 | — | $89.1M | ||
| Q4 25 | $244.3M | — | ||
| Q3 25 | — | $-12.1M | ||
| Q2 25 | — | $-11.1M | ||
| Q1 25 | — | $-26.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-13.4M | ||
| Q2 24 | — | $-16.8M |
毛利率BEAMRBBN
| Q1 26 | — | 42.9% | ||
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 50.1% | ||
| Q2 25 | — | 49.6% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 50.8% |
营业利润率BEAMRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | -15.3% | 4.1% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | -10.8% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | -0.4% | ||
| Q2 24 | — | -1.0% |
净利率BEAMRBBN
| Q1 26 | — | 54.8% | ||
| Q4 25 | 214.1% | — | ||
| Q3 25 | — | -5.6% | ||
| Q2 25 | — | -5.0% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -6.4% | ||
| Q2 24 | — | -8.7% |
每股收益（稀释后）BEAMRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $2.53 | $0.50 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | — | $-0.08 | ||
| Q2 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $419.1M |
| 总资产 | $1.5B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BEAMRBBN
| Q1 26 | — | $67.6M | ||
| Q4 25 | $1.2B | $96.4M | ||
| Q3 25 | — | $74.8M | ||
| Q2 25 | — | $60.5M | ||
| Q1 25 | — | $71.2M | ||
| Q4 24 | — | $87.8M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $64.6M |
总债务BEAMRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益BEAMRBBN
| Q1 26 | — | $419.1M | ||
| Q4 25 | $1.2B | $449.0M | ||
| Q3 25 | — | $360.1M | ||
| Q2 25 | — | $370.4M | ||
| Q1 25 | — | $381.8M | ||
| Q4 24 | — | $404.6M | ||
| Q3 24 | — | $395.5M | ||
| Q2 24 | — | $405.0M |
总资产BEAMRBBN
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B |
负债/权益比BEAMRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-83.3M | — |
| 自由现金流经营现金流 - 资本支出 | $-87.0M | — |
| 自由现金流率自由现金流/营收 | -76.3% | — |
| 资本支出强度资本支出/营收 | 3.3% | — |
| 现金转化率经营现金流/净利润 | -0.34× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BEAMRBBN
| Q1 26 | — | — | ||
| Q4 25 | $-83.3M | $29.2M | ||
| Q3 25 | — | $26.5M | ||
| Q2 25 | — | $-795.0K | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $61.8M | ||
| Q3 24 | — | $-14.8M | ||
| Q2 24 | — | $-9.8M |
自由现金流BEAMRBBN
| Q1 26 | — | — | ||
| Q4 25 | $-87.0M | $27.3M | ||
| Q3 25 | — | $21.0M | ||
| Q2 25 | — | $-6.5M | ||
| Q1 25 | — | $-15.7M | ||
| Q4 24 | — | $53.8M | ||
| Q3 24 | — | $-23.7M | ||
| Q2 24 | — | $-12.9M |
自由现金流率BEAMRBBN
| Q1 26 | — | — | ||
| Q4 25 | -76.3% | 12.0% | ||
| Q3 25 | — | 9.7% | ||
| Q2 25 | — | -2.9% | ||
| Q1 25 | — | -8.7% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -6.7% |
资本支出强度BEAMRBBN
| Q1 26 | — | — | ||
| Q4 25 | 3.3% | 0.9% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | 1.6% |
现金转化率BEAMRBBN
| Q1 26 | — | — | ||
| Q4 25 | -0.34× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BEAM
| Pfizer | $109.1M | 96% |
| Other | $5.0M | 4% |
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
